0001022079-19-000090.txt : 20190305 0001022079-19-000090.hdr.sgml : 20190305 20190305162909 ACCESSION NUMBER: 0001022079-19-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doherty Catherine T. CENTRAL INDEX KEY: 0001520897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 19658829 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_155182133616795.xml FORM 4 X0306 4 2019-03-01 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001520897 Doherty Catherine T. 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 SVP, Group Exec. Clin. Fran. Common Stock 2019-03-01 4 A 0 7669 86.86 A 77193 D Common Stock 2019-03-01 4 F 0 3777 86.86 D 73416 D Common Stock 3925 I 401(k)/SDCP Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d). Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. /s/ Elena H. Radine, Attorney in Fact for Catherine T. Doherty 2019-03-05